Drug maker Strides Shasun Ltd on Monday said that it had entered into an agreement with Sweden-based Moberg Pharma AB and its affiliates to acquire three over-the-counter (OTC) brands for $10 million (Rs.67 crore) plus inventory value.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
